WeVote

Bill

Bill

H 4760

Abortion-Inducing Drugs

2025-2026 Regular Session Introduced by Phillip Bowers and 38 co-sponsors

South Carolina House bill restricts medication abortion access by limiting prescriber eligibility and drug distribution protocols, passing 76-28 before Senate referral.

Scrivener's error corrected
0
WeVote Research Nonpartisan
Bill Summary · H 4760

Legislative bill overview

H 4760 restricts access to medication abortion (mifepristone and misoprostol) in South Carolina by limiting who can prescribe these drugs and under what circumstances they can be distributed. The bill passed the House with significant support (76-28) and has been referred to the Senate for consideration.

Why is this important

Medication abortion accounts for over half of all abortions nationally and is increasingly used in early pregnancy. This bill would substantially limit reproductive healthcare options for South Carolina residents and potentially affect providers' ability to offer comprehensive reproductive medicine services.

Potential points of contention

  • Medical consensus vs. legal restrictions: Major medical organizations (ACOG, AMA) support medication abortion access, but the bill restricts it beyond current FDA protocols
  • Interstate travel and access: Restrictions may push residents to seek care in neighboring states, raising questions about enforcement and practical effectiveness
  • Provider liability and practice impacts: Unclear regulatory requirements could deter healthcare providers from offering services, further limiting access within the state
  • Constitutional challenges: Similar laws face ongoing litigation regarding constitutional protections for abortion access and medical decision-making autonomy

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.